Search Results for 'novartis'
-
cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Codexis, Novartis Ink Tech Transfer and License Agreement
Novartis to leverage CodeEvolver protein engineering platform technology develop performance enzymes for use in manufacturing05.15.19
-
Breaking News | Industry News
Novartis Buys Dry Eye Drug from Takeda for $5.3B
Takeda also divests TachoSil to Ethicon for $400 million05.10.19
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Novartis, Blackstone Launch Anthos Therapeutics
Will develop medicines for cardiovascular disease02.28.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
AbCellera & Novartis Announce Collaboration
AbCellera to apply technology to advance programs on up to ten targets elected by Novartis02.15.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Novartis Makes Offer for French CDMO
Proposed acquisition builds on existing agreement with CellforCure for contract manufacturing of Novartis' leading CAR-T cell therapy Kymriah12.26.18
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Galapagos and MorphoSys Partner with Novartis
Novartis will cover development and commercialization costs of their joint program, MOR10607.19.18
-
Head of Novartis Pharmaceuticals David Epstein Shares His Vision for the Future
Thinking beyond the pill – exploring diagnostic tools, digital support and data analysis to provide better care worldwide.Videos
-
Biosimilars
02 Novartis
#2: Novartis Headcount 119,418 Year Established 1996 Pharma Revenues &n…Gil Roth 07.14.11
-
Breaking News | Industry News
UCB, Novartis Expand License Agreement
UCB and Novartis entered into a license agreement for cardiovascular and diabetes products in Germany.08.24.09
